BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 23, 2006
View Archived Issues
Medivir reports significant events of the fourth quarter 2005
Read More
Development and preclinical efficacy of a novel T-cell HCV vaccine (MRKAd6-NSmut)
Read More
Spectrum reviews past year's highlights
Read More
Novel antiinfective agents reported in recent patent literature
Read More
Novel antidiabetic agents patented
Read More
New compounds with possible applicability in the treatment of inflammatory disorders described
Read More
Neuromed and Merck collaborate on novel N-type calcium channel compounds
Read More
Aquavan begins pivotal phase III program
Read More
Enrollment completed in phase II study of TH-070 for BPH
Read More
Fas-targeting fusion protein to enter clinic later this year
Read More
Satraplatin and JM-118 tested for antiangiogenic activity
Read More
Imatinib's exposure independent of ABCB1, ABCG2 and CYP3A4
Read More
Cancer cell specific apoptosis evoked by novel transcriptional inhibitor
Read More
Asthma therapy efficacious in ALS
Read More
Phase III trials of intravenous iclaprim cleared to continue
Read More
Samaritan's Alzheimer's adult stem cell drug progresses through preclinical testing
Read More
PhytoMedical expands type 2 diabetes research agreement into Alzheimer's
Read More
Curis achieves preclinical milestone in hair growth program with P&G
Read More
VISER1 trial results for Viramidine in hepatitis C
Read More
PolyMedix receives SBIR grant to develop novel antibiotic drugs
Read More
Savient and FDA agree on phase III protocol SPA for Puricase
Read More
FDA approval of expanded label for Remodulin
Read More
Additional data from phase I/II study of HuMax-CD20 in rheumatoid arthritis
Read More
Nabi outlines new plans for Gram-positive program
Read More
FDA extends review period for Tysabri in MS
Read More
Promising new therapeutic target in atherosclerosis reported / News in Context
Read More
Effective prevention of trachoma recurrence with azithromycin reported / News in Context
Read More